Valneva SE announced the earnings guidance for 2024. For the year Product sales expected between ?150 million and ?180 million, reflecting continued revenue growth for proprietary products and IXCHIQ®?s launch-year sales, despite anticipated supply constraints for third-party products and IXIARO®.